814 Cutaneous immune-related adverse events are protective of mortality in patients treated with anti-PD1 and anti-PDL1 therapy in a multi-institutional cohort study

Yevgeniy Semenov; Kimberly Tang; Jayhyun Seo; Kerry Reynolds; Bruce Tiu; Thomas Le; Vartan Pahalyants; Neel Raval; Pearl Ugwu-Dike; Leyre Zubiri; Vivek Naranbhai; Alexander Gusev; Nicole LeBoeuf; Maryam Asgari; Shawn Kwatra

doi:10.1136/jitc-2021-SITC2021.814

Article info

Regular and Young Investigator Award Abstracts

Immunotherapy Toxicities

814 Cutaneous immune-related adverse events are protective of mortality in patients treated with anti-PD1 and anti-PDL1 therapy in a multi-institutional cohort study

Free

Authors

Yevgeniy Semenov Massachusetts General Hospital/Harvard Medical School, Boston, MA, MA, United States PubMed articles Google scholar articles
Kimberly Tang Massachusetts General Hospital, Boston, MA, United States PubMed articles Google scholar articles
Jayhyun Seo Massachusetts General Hospital, Boston, MA, United States PubMed articles Google scholar articles
Kerry Reynolds Massachusetts General Hospital, Boston, MA, United States PubMed articles Google scholar articles
Bruce Tiu Harvard Medical School, Boston, MA, United States PubMed articles Google scholar articles
Thomas Le Johns Hopkins University, Baltimore, MD, United States PubMed articles Google scholar articles
Vartan Pahalyants Harvard Medical School, Boston, MA, United States PubMed articles Google scholar articles
Neel Raval Massachusetts General Hospital, Boston, MA, United States PubMed articles Google scholar articles
Pearl Ugwu-Dike Massachusetts General Hospital, Boston, MA, United States PubMed articles Google scholar articles
Leyre Zubiri Massachusetts General Hospital, Boston, MA, United States PubMed articles Google scholar articles
Vivek Naranbhai Massachusetts General Hospital, Boston, MA, United States PubMed articles Google scholar articles
Alexander Gusev Dana Farber Cancer Institute, Boston, MA, United States PubMed articles Google scholar articles
Nicole LeBoeuf Dana Faber Cancer Institute, Boston, MA, United States PubMed articles Google scholar articles
Maryam Asgari Harvard Medical School, Boston, MA, United States PubMed articles Google scholar articles
Shawn Kwatra Johns Hopkins University, Baltimore, MD, United States PubMed articles Google scholar articles

Citation

Semenov Y, Tang K, Seo J, et al

814 Cutaneous immune-related adverse events are protective of mortality in patients treated with anti-PD1 and anti-PDL1 therapy in a multi-institutional cohort study

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.814

Publication history

First published November 10, 2021.

Online issue publication

March 30, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password